LLY

914.01

+1.22%↑

JNJ

235.73

+0.11%↑

ABBV

205.66

+0.7%↑

NVS

148.79

+1.99%↑

AZN

185.14

+0.97%↑

LLY

914.01

+1.22%↑

JNJ

235.73

+0.11%↑

ABBV

205.66

+0.7%↑

NVS

148.79

+1.99%↑

AZN

185.14

+0.97%↑

LLY

914.01

+1.22%↑

JNJ

235.73

+0.11%↑

ABBV

205.66

+0.7%↑

NVS

148.79

+1.99%↑

AZN

185.14

+0.97%↑

LLY

914.01

+1.22%↑

JNJ

235.73

+0.11%↑

ABBV

205.66

+0.7%↑

NVS

148.79

+1.99%↑

AZN

185.14

+0.97%↑

LLY

914.01

+1.22%↑

JNJ

235.73

+0.11%↑

ABBV

205.66

+0.7%↑

NVS

148.79

+1.99%↑

AZN

185.14

+0.97%↑

Search

Quidel Corp

Abrir

16.68 9.66

Visão Geral

Variação de preço das ações

24h

Atual

Mín

15.21

Máximo

17.06

Indicadores-chave

By Trading Economics

Rendimento

602M

-131M

Vendas

24M

724M

Margem de lucro

-18.062

Funcionários

6,500

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+101.77% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-172M

1B

Abertura anterior

7.02

Fecho anterior

16.68

Quidel Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de mar. de 2026, 23:50 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

22 de mar. de 2026, 23:50 UTC

Conversa de Mercado

LG Electronics Set to Stage Strong Earnings Rebound in 1Q -- Market Talk

22 de mar. de 2026, 23:49 UTC

Conversa de Mercado
Notícias Principais

Gold Edges Lower on Prospects of Liquidity-Driven Sales -- Market Talk

22 de mar. de 2026, 23:49 UTC

Conversa de Mercado
Notícias Principais

Nikkei May Fall as Concerns About Middle East Conflict Persist -- Market Talk

22 de mar. de 2026, 23:49 UTC

Conversa de Mercado
Notícias Principais

Global Forex and Fixed Income Roundup: Market Talk

22 de mar. de 2026, 23:41 UTC

Conversa de Mercado
Notícias Principais

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz -- Market Talk

22 de mar. de 2026, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

Perseus Mining: Location of Aurum's Discoveries Present Potential Future Synergies

22 de mar. de 2026, 22:56 UTC

Aquisições, Fusões, Aquisições de Empresas

Perseus Mining: Aurum Share Acquisition Cost A$23.69 Million

22 de mar. de 2026, 22:56 UTC

Aquisições, Fusões, Aquisições de Empresas

Perseus Mining: Aurum's Boundiali Gold Project Located to South of Sissingue Gold Mine

22 de mar. de 2026, 22:55 UTC

Aquisições, Fusões, Aquisições de Empresas

Perseus Mining: Participated in Aurum Resources Equity Raising

22 de mar. de 2026, 22:54 UTC

Aquisições, Fusões, Aquisições de Empresas

Perseus Mining: Acquires 9.9% Interest in Aurum Resources

22 de mar. de 2026, 22:22 UTC

Conversa de Mercado
Notícias Principais

After Selloff, Gold Seen Supported by Strait of Hormuz Deadline -- Market Talk

22 de mar. de 2026, 22:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Synopsys Has Market Value Over $80 Billion; Major Customers Include Nvidia -- WSJ

22 de mar. de 2026, 22:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys -- WSJ

22 de mar. de 2026, 22:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Activist Elliott Investment Management Has Multibillion-Dollar Investment in Synopsys, Sources Say -- WSJ

22 de mar. de 2026, 22:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Elliott Plans to Push Synopsys to Make More Money From Its Software and Services, Sources Say -- WSJ

22 de mar. de 2026, 21:53 UTC

Ganhos

Zijin Gold International Plans 59.2 Tons of Gold Production in 2026; up 12.3% on Year >2259.HK

22 de mar. de 2026, 21:53 UTC

Ganhos

Zijin Gold International Rising Gold Prices Supported Results >2259.HK

22 de mar. de 2026, 21:53 UTC

Ganhos

Zijin Gold International 2025 Rev $5.38B Vs. $2.99B >2259.HK

22 de mar. de 2026, 21:53 UTC

Ganhos

Zijin Gold International 2025 Net $1.60B Vs. Net $481.37M >2259.HK

22 de mar. de 2026, 21:31 UTC

Ganhos

China Petroleum & Chemical Plans CNY131.6B-CNY148.6B Capex Spending in 2026>0386.HK

22 de mar. de 2026, 21:31 UTC

Ganhos

China Petroleum & Chemical: Decrease in Sales Volumes of Refined Oil Products Also Hurt Results >0386.HK

22 de mar. de 2026, 21:31 UTC

Ganhos

China Petroleum & Chemical 2025 Results Weighed by Decrease in Prices of Petroleum, Petrochemical Products>0386.HK

22 de mar. de 2026, 21:31 UTC

Ganhos

China Petroleum & Chemical 2025 Rev CNY2.78T Vs. CNY3.07T >0386.HK

22 de mar. de 2026, 21:31 UTC

Ganhos

China Petroleum & Chemical 2025 Net CNY32.48B Vs. Net CNY48.94B >0386.HK

22 de mar. de 2026, 21:25 UTC

Conversa de Mercado
Notícias Principais

Bonds Decoupling From Oil Amid Longer Conflict Fears -- Market Talk

22 de mar. de 2026, 21:22 UTC

Aquisições, Fusões, Aquisições de Empresas

St Barbara: Remarks Follow Recent Inquiries About Simberi's Fuel Stocks

22 de mar. de 2026, 21:21 UTC

Aquisições, Fusões, Aquisições de Empresas

St Barbara: Simberi Currently Uses About 65,000 Liters Per Day For Mining Fleet, Power Generation

22 de mar. de 2026, 21:21 UTC

Conversa de Mercado

Revised Fuel Subsidy Mechanism Positive for Ampol, Viva Energy -- Market Talk

22 de mar. de 2026, 21:21 UTC

Aquisições, Fusões, Aquisições de Empresas

St Barbara: Has Been Taking Precaution to Increase Diesel Storage For Several Months

Comparação entre Pares

Variação de preço

Quidel Corp Previsão

Preço-alvo

By TipRanks

101.77% parte superior

Previsão para 12 meses

Média 30.75 USD  101.77%

Máximo 38 USD

Mínimo 25 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Quidel Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

1

Comprar

3

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

Resultado Operacional

$

Sobre Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat